IP & patents · Pipeline & development
Anixa Biosciences Announces Issuance of Canadian Patent Strengthening International Protection for its Ovarian Cancer Vaccine Technology
New patent expands Anixa's intellectual property portfolio for its innovative ovarian cancer vaccine, complementing existing U.S. patent protection SAN JOSE, Calif., Nov. 19, 2026 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company...
Original source
Read the source — prnewswire.com ↗We link to the original publisher. The summary above is a short guide; read the original for the full details.